retatrutide liver Triple hormone receptor agonist for metabolic dysfunction-associated steatotic disease: a randomized phase 2a trial Retatrutide vs Tirzepatide: Which Weight-Loss
Description
Martinelli, S., Mazzotta, A., Longaroni, M., & Petrucciani, N
4, DF )
Nutrition 26, 243249
Katsiougiannis S, Kapsogeorgou EK, Manoussakis MN, Skopouli FN
They change digestion, gut microbes, nutrient flows, and appetite signals
Participants lost more weight when they used both treatments compared to those who used only one
